Video Download: New Study Says The Benefits Of Testosterone Replacement Therapy Outweigh The Risks.zip
Video Stream: New Study Says The Benefits Of Testosterone Replacement Therapy Outweigh The Risks
The benefits of Testosterone Replacement Therapy (TRT) to treat low Testosterone in both men and women substantially outweigh any risks according to the results of a new study presented at the American Association of Clinical Endocrinologists’ (AACE) 24th Annual Scientific and Clinical Congress.
Low Testosterone -- also known as “low-T” -- is characterized by the lack of sex drive, diminishing energy, hair, bone, and muscle mass loss, joint aches and pains, accumulated slabs of fat, depression, and mental confusion, or “brain fog.”
The panel was responding to the Food and Drug Administration's (FDA) safety alert issued in March 2015 warning that the benefits and safety of Testosterone medications prescribed for age-related low Testosterone levels have not been proven.
In that statement, the FDA also called for manufacturers to include labeling warning of a possible increased risk of heart attacks and strokes.
Endocrinologist Sandeep Dhindsa MD declared that the FDA provided no meaningful definition of aging, leaving it unclear if age restrictions for Testosterone therapy also apply to mature individuals.
Dr. Dhindsa added that the safety alert does not address the role that Testosterone decline itself plays in common co-morbidities such as obesity and type 2 diabetes at all ages, including adolescents and young men.
“Any patient being considered for testosterone replacement therapy should undergo a thorough diagnostic workup,” Dr. Dhindsa said.
“The decision to replace testosterone therapy should be guided by the signs, symptoms and testosterone concentrations rather than the underlying cause,” he said.
Susan Davis, MBBS FRACP Ph.D. and Director of the Women’s Health Research Program in the School of Public Health and Preventive Medicine Monash University Melbourne also touted the safety and efficacy of TRT in women experiencing hypoactive sexual desire disorder (HSDD), a condition that persistently affects female sexual function profoundly impairing quality of life.
“Testosterone has been used to treat women with HSDD for decades with no evidence of emergent adverse events and should be seen as an efficient and safe management option not just for sexual function but also for effects on muscle and bone,” Dr. Davis said.
Their comments agreed with the soon-to-be-published AACE Reproductive Endocrinology position statement on the association between Testosterone and cardiovascular risks which note that there is no compelling evidence that TRT either increases or decreases cardiovascular risks.
They concluded that Testosterone therapy dramatically slashes many cardiovascular risk factors by decreasing fat mass, increasing muscle mass and decreasing insulin resistance.
Word Count: 413
Contact Us Today For A Free Consultation
- Think women don’t need testosterone? Think again! - October 19th, 2018
- Testosterone Replacement Therapy Lowers Heart Attack Risk - October 9th, 2018
- Menopause: It's Not Just a Woman's Problem - September 18th, 2018
- In the Battle Against Aging, When do the Risks Outweigh the Rewards? - September 15th, 2018
- Testosterone Therapy — Good Idea or Not? - September 10th, 2018
- Judge Vacates $140 Million Verdict in Testosterone Lawsuit - August 1st, 2018
- The Great Testosterone Debate - July 30th, 2018
- Did You Know? Recent Studies Have Confirmed the Link Between Low Testosterone (“Low-T”) and Depression. - June 27th, 2018
- Sex Hormone-Binding Globulin - April 6th, 2018
- Testosterone: The Master Protector - March 5th, 2018
- Did You Know: Low Testosterone Levels Can Predict Metabolic Syndrome - March 2nd, 2018
- Testosterone Therapy - February 5th, 2018
- Testosterone Replacement Does Not Cause Heart Attacks - February 1st, 2018
- Fed Up With Looking in the Mirror and Not Liking What You See? - January 12th, 2018
- New Study Finds Testosterone Does Not Increase Your Heart Attack Risk - January 8th, 2018
- LabCorp Announces a Change to the Testosterone Reference Range - January 5th, 2018
- Lipocine Announces Positive Top-Line Results in Phase 2a Study of LPCN 1111 - December 26th, 2017
- Low-T and Older Men: Twice the Risk for Health Problems - December 26th, 2017
- Testosterone Replacement Therapy (TRT) May Prevent Heart Attacks and Diabetes - December 21st, 2017
- More Reasons to Consider Testosterone Replacement Therapy - December 19th, 2017
- New Study Concludes: Boosting Testosterone Levels Lowers Men's Death Risk - December 19th, 2017
- Testosterone Replacement Therapy: A Medical Alternative to Bariatric Surgery? - December 18th, 2017
- Male Menopause. Fact or Fiction ? - August 7th, 2017